Theriva Biologics, Inc.
$0.23
-$0.01 (-3.51%)
$0.23Day Range$0.24
Key Statistics
Market Cap
$11.11M
Shares Outstanding
45.9M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
Apr 5, 1993
Round Lot
100
Locale
US
Trading Data
Day Open
$0.24
Day High
$0.24
Day Low
$0.23
Volume
198.6K
VWAP
$0.24
Prev Close
$0.24
Transactions
--
Acc. Volume
--
About Theriva Biologics, Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
PHARMACEUTICAL PREPARATIONSSIC 283416 employees9605 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850(734) 332-7800IPO Apr 5, 1993US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000894158
- Composite FIGI
- BBG000BV6QX8
- Share Class FIGI
- BBG001S77L07
- Ticker Root
- TOVX
- SIC Code
- 2834
About Theriva Biologics, Inc. (TOVX) Stock
Theriva Biologics, Inc. (TOVX) closed the 2026-09-18 session at $0.23, down 3.51% versus the previous close (-0.01). The stock opened at $0.24 and traded between $0.23 and $0.24 during that session. Session trading volume was 199K shares. The volume-weighted average price (VWAP) is $0.24.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
Theriva Biologics, Inc. has a market capitalization of $11.1 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. TOVX is listed on the XASE exchange. The company employs approximately 16 people. Theriva Biologics, Inc. is headquartered in ROCKVILLE, MD. The recorded listing date is 1993-04-05.
On this page you can find market TOVX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.